Pharmaceuticals
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters The Food and Drug Administration’s independent panel of advisors recommended full approval of Pfizer’s Covid-19 antiviral pill Paxlovid for high-risk adults 16-1 on Thursday, but flagged potentially harmful drug interactions. The treatment […]
Read More
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
President Joe Biden delivers remarks about the Build Back Better legislation’s new rules around prescription drug prices in the East Room of the White House on December 06, 2021 in Washington, DC. Chip Somodevilla | Getty Images Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President Joe […]
Read More
FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5
A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center. Sebastian Christoph Gollnow | dpa | Picture Alliance | Getty Images The U.S. Food and Drug Administration on Tuesday authorized Pfizer’s omicron booster shot for kids under five years old […]
Read More
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
In this photo illustration, Pfizer’s Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. Joe Raedle | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support the drug’s use in adults at high risk of progressing to severe disease. The […]
Read More
Citing ‘death threats,’ Texas judge asked attorneys to keep news of hearing on legality of abortion pill quiet
Citing death threats and harassing phone calls, the federal judge who is presiding over a pivotal case that could decide the future of the abortion pill in the U.S. asked attorneys not to publicize the date of a key hearing, telling them “less advertisement is better.” Judge Matthew Kacsmaryk of the U.S. Northern District of […]
Read More
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Novo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Novo Nordisk on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in the U.S., becoming the […]
Read More
CNBC Day-to-day Open up: Banking institutions acquired hammered by SVB’s collapse. But the Fed could possibly continue to elevate premiums
The exterior of a First Republic Financial institution branch is seen on Barclay Street on March 13, 2023 in New York Metropolis. Michael M. Santiago | Getty Visuals Information | Getty Photographs This report is from present-day CNBC Every day Open, our new, global markets e-newsletter. CNBC Everyday Open delivers traders up to pace on […]
Read More
Veterans Health Administration will cover Alzheimer’s treatment Leqembi, Eisai says
The Veterans Health Administration will cover Eisai and Biogen‘s Alzheimer’s treatment Leqembi, the companies announced Monday. In a statement, drugmaker Eisai said veterans in the early stages of the disease who meet VHA criteria are eligible for coverage of Leqembi. The decision by VHA stands in contrast with Medicare, which has declined to cover the […]
Read More
Watch live: Biden warns of GOP plans to curb access to health-care
(The stream is slated to start at 3 p.m. ET. Please refresh the page if you do not see a video above at that time.) U.S. President Joe Biden will deliver a blistering criticism of Republican policies at a speech in Virginia Beach on Tuesday afternoon where he will warn of GOP plans to cut […]
Read More
Op-ed: DEA and Fda procedures exacerbate Adderall scarcity
30mg tablets of Shire Plc’s Adderall XR. JB Reed | Bloomberg | Getty Photographs Josh Disbrow is chairman and CEO of Aytu BioPharma, which will make a competing drug to treat ADHD called Adzenys XR-ODT. A nationwide scarcity of Adderall has still left several clients battling to deal with their awareness deficit hyperactivity condition, better acknowledged […]
Read More